[1]Barratt J, Feehally J. Treatment of IgA nephropathy[J]. Kidney international, 2006, 69(11): 1934-1938.[2]Han X, Xiao Y, Tang Y, et al. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome[J]. Clinical and experimental medicine, 2019, 19(4): 479-486.[3]李娅,王伟铭,任红,张文,沈平雁,王朝晖,李晓,贾晓媛,陈楠.沷尼松联合环磷酰胺治疗免疫球蛋白A肾病伴肾病综合征和肾功能不全[J].上海医学,2012,35(09):746-750.[4]Herlitz L C, Bomback A S, Stokes M B, et al. IgA nephropathy with minimal change disease[J]. Clinical Journal of the American Society of Nephrology, 2014, 9(6): 1033-1039.[5]Kim J K, Kim J H, Lee S C, et al. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome[J]. Clinical journal of the American Society of Nephrology, 2012, 7(3): 427-436.[6]Di Iorio B, Torraca S, Gustaferro P, et al. High-frequency external muscle stimulation in acute kidney injury (AKI): potential shortening of its clinical course[J]. Clin Nephrol, 2013, 79(Suppl 1): S37-S45.[7]Li X W, Cheng S Q, Liang S S, et al. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease[J]. Clinical nephrology, 2016, 85(5): 273-281.本文首发:医学界肾病频道本文作者:桂枝责任编辑:风禾